Jundishapur Journal of Microbiology

Published by: Kowsar

The Relationship Between Antibiotic Resistance Phenotypes and Biofilm Formation Capacity in Clinical Isolates of Acinetobacter baumannii

Sara Rahimi 1 , Zahra Farshadzadeh 2 , 3 , Behrouz Taheri 4 , Mohsen Mohammadi 5 , Mohammad-Ali Haghighi 1 , * and Abbas Bahador 6
Authors Information
1 Department of Microbiology and Parasitology, Faculty of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran
2 Department of Microbiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3 Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
4 Department of Medical Laboratory Sciences, School of Paramedicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
5 The Persian Gulf Marine Biotechnology Research Center, the Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran
6 Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Jundishapur Journal of Microbiology: August 2018, 11 (8); e74315
  • Published Online: July 18, 2018
  • Article Type: Research Article
  • Received: May 9, 2018
  • Revised: June 26, 2018
  • Accepted: June 27, 2018
  • DOI: 10.5812/jjm.74315

To Cite: Rahimi S, Farshadzadeh Z, Taheri B, Mohammadi M, Haghighi M, et al. The Relationship Between Antibiotic Resistance Phenotypes and Biofilm Formation Capacity in Clinical Isolates of Acinetobacter baumannii, Jundishapur J Microbiol. 2018 ; 11(8):e74315. doi: 10.5812/jjm.74315.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Singhai M, Malik A, Shahid M, Malik MA, Goyal R. A study on device-related infections with special reference to biofilm production and antibiotic resistance. J Glob Infect Dis. 2012;4(4):193-8. doi: 10.4103/0974-777X.103896. [PubMed: 23326076]. [PubMed Central: PMC3543538].
  • 2. Farshadzadeh Z, Taheri B, Rahimi S, Shoja S, Pourhajibagher M, Haghighi MA, et al. Growth rate and biofilm formation ability of clinical and laboratory-evolved colistin-resistant strains of Acinetobacter baumannii. Front Microbiol. 2018;9:153. doi: 10.3389/fmicb.2018.00153. [PubMed: 29483899]. [PubMed Central: PMC5816052].
  • 3. He X, Lu F, Yuan F, Jiang D, Zhao P, Zhu J, et al. Biofilm formation caused by clinical Acinetobacter baumannii isolates is associated with overexpression of the adeFGH efflux pump. Antimicrob Agent Chemother. 2015;59(8):4817-25. doi: 10.1128/AAC.00877-15. [PubMed: 26033730]. [PubMed Central: PMC4505227].
  • 4. Hu Y, He L, Tao X, Meng F, Zhang J. Biofilm may not be Necessary for the Epidemic Spread of Acinetobacter baumannii. Sci Rep. 2016;6:32066. doi: 10.1038/srep32066. [PubMed: 27558010]. [PubMed Central: PMC4997352].
  • 5. Perez LR. Acinetobacter baumannii displays inverse relationship between meropenem resistance and biofilm production. J Chemother. 2015;27(1):13-6. doi: 10.1179/1973947813Y.0000000159. [PubMed: 24621167].
  • 6. Qi L, Li H, Zhang C, Liang B, Li J, Wang L, et al. Relationship between Antibiotic Resistance, Biofilm Formation, and Biofilm-Specific Resistance in Acinetobacter baumannii. Front Microbiol. 2016;7:483. doi: 10.3389/fmicb.2016.00483. [PubMed: 27148178]. [PubMed Central: PMC4828443].
  • 7. Gurung J, Khyriem AB, Banik A, Lyngdoh WV, Choudhury B, Bhattacharyya P. Association of biofilm production with multidrug resistance among clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa from intensive care unit. Indian J Crit Care Med. 2013;17(4):214-8. doi: 10.4103/0972-5229.118416. [PubMed: 24133328]. [PubMed Central: PMC3796899].
  • 8. Higgins PG, Lehmann M, Wisplinghoff H, Seifert H. gyrB multiplex PCR to differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3. J Clin Microbiol. 2010;48(12):4592-4. doi: 10.1128/JCM.01765-10. [PubMed: 20881170]. [PubMed Central: PMC3008493].
  • 9. Turton JF, Gabriel SN, Valderrey C, Kaufmann ME, Pitt TL. Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect. 2007;13(8):807-15. doi: 10.1111/j.1469-0691.2007.01759.x. [PubMed: 17610600].
  • 10. Pourcel C, Minandri F, Hauck Y, D'Arezzo S, Imperi F, Vergnaud G, et al. Identification of variable-number tandem-repeat (VNTR) sequences in Acinetobacter baumannii and interlaboratory validation of an optimized multiple-locus VNTR analysis typing scheme. J Clinical Microbiol. 2010;49(2):539-48. doi: 10.1128/jcm.02003-10.
  • 11. Clinical and Laboratory Standards Institute [CLSI]. Performance standards for antimicrobial susceptibility testing; twenty fourth informational supplement M100-S25. Wayne, PA: CLSI; 2015.
  • 12. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268-81. doi: 10.1111/j.1469-0691.2011.03570.x. [PubMed: 21793988].
  • 13. Hung KH, Wang MC, Huang AH, Yan JJ, Wu JJ. Heteroresistance to cephalosporins and penicillins in Acinetobacter baumannii. J Clin Microbiol. 2012;50(3):721-6. doi: 10.1128/JCM.05085-11. [PubMed: 22189112]. [PubMed Central: PMC3295183].
  • 14. Farshadzadeh Z, Hashemi FB, Rahimi S, Pourakbari B, Esmaeili D, Haghighi MA, et al. Wide distribution of carbapenem resistant Acinetobacter baumannii in burns patients in Iran. Front Microbiol. 2015;6:1146. doi: 10.3389/fmicb.2015.01146. [PubMed: 26539176]. [PubMed Central: PMC4611150].
  • 15. Yu Y, Chen M, Jinli L, Su J. Clinical and molecular epidemiological characterization of extensively drug-resistant Acinetobacter baumannii in patients with liver disease. Int J Clin Exp Med. 2016;9(7):13127-34.
  • 16. Azimi L, Talebi M, Pourshafie MR, Owlia P, Rastegar Lari A. Characterization of carbapenemases in extensively drug resistance Acinetobacter baumannii in a burn care center in Iran. Int J Mol Cell Med. 2015;4(1):46-53. [PubMed: 25815282]. [PubMed Central: PMC4359705].
  • 17. Bahador A, Raoo An R, Farshadzadeh Z, Beitollahi L, Khaledi A, Rahimi S, et al. The prevalence of IS Aba 1 and IS Aba 4 in Acinetobacter baumannii species of different international clone lineages among patients with burning in Tehran, Iran. Jundishapur J Microbiol. 2015;8(7). e17167. doi: 10.5812/jjm.17167v2. [PubMed: 26396712]. [PubMed Central: PMC4575776].
  • 18. Bahador A, Raoofian R, Taheri M, Pourakbari B, Hashemizadeh Z, Hashemi FB. Multidrug resistance among Acinetobacter baumannii isolates from Iran: changes in antimicrobial susceptibility patterns and genotypic profile. Microb Drug Resist. 2014;20(6):632-40. doi: 10.1089/mdr.2013.0146. [PubMed: 25029126].
  • 19. Bahador A, Taheri M, Pourakbari B, Hashemizadeh Z, Rostami H, Mansoori N, et al. Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants. Microb Drug Resist. 2013;19(5):397-406. doi: 10.1089/mdr.2012.0233. [PubMed: 23768166].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments